A Community Screening Program for Helicobacter pylori Saves Money: 10-Year Follow-up of a Randomized Controlled Trial

References

Page 1

	Year	Citations
Cancer incidence, mortality and prevalence worldwide J Ferlay Medical Entomology and Zoology Cancer RiskCancer EpidemiologyMedicineGlobal HealthEpidemiology Of Cancer	2004	3.8K
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China Benjamin Chun–Yu Wong, Shiu Kum Lam, Wai Man Wong, JAMA	2004	1.4K
HELICOBACTER PYLORI AND GASTRIC CANCER Julie Parsonnet Gastroenterology Clinics of North America Gastrointestinal OncologyMedicineGastroenterologyPathologyOncology	1993	348
Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials Julie Parsonnet, Ryan A. Harris, Howard M. Hack, The Lancet	1996	332
Seroconversion for Helicobacter pylori Ernst J. Kuipers, A. S. Peña, N. F. M. Pels, The Lancet Medical MicrobiologyHealth SciencesMicrobiologyMolecular MicrobiologyMedicine	1993	232
Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial Paul Moayyedi, Richard Feltbower, Julia Brown, The Lancet Preventive MedicineHelicobacter PyloriGastroenterologyPublic HealthMedicine	2000	174
The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia Paul Moayyedi, Duffett, Braunholtz, Alimentary Pharmacology & Therapeutics	1998	135
The cost‐effectiveness of population <i>Helicobacter pylori</i> screening and treatment: a Markov model using economic data from a randomized controlled trial James Mason, Anthony Axon, D Forman, Alimentary Pharmacology & Therapeutics	2002	97
Significance of Helicobacter Pylori Infection and Gastric Cancer: Implications for Screening Paul Moayyedi, Michael F. Dixon Gastrointestinal Endoscopy Clinics of North America Helicobacter Pylori InfectionGastrointestinal OncologyGastroenterologyPathologyClinical Gastroenterology	1997	15

Page 1